Ideas to Action:

Independent research for global prosperity

Global Health Policy

CGD experts discuss such issues as health financing, drug resistance, clinical trials, vaccine development, HIV/AIDS, and health-related foreign assistance.

X

Global Health Policy

Feed

 

Terminology Matters: The Dispute between India and EU over Generic Drug Transshipments

Over the last sixteen months, EU customs officials have impounded more than 20 shipments of pharmaceutical products manufactured by Indian companies. The EU maintains these seizures were intended to prevent trade in counterfeit medicines. India argues the EU is targeting developing country drug manufacturers and undermining access to lawful, safe, and low-cost generic drugs in developing country markets. Last week, India announced plans to seek settlement of the dispute at the World Trade Organization (WTO).

Committing to Child Survival: What are the Priorities?

Americans are broadly supportive of the efforts to reduce the tragic toll of AIDS, in part because they know that many children are affected by the disease and children's health has always been one of the highest priorities voiced in public opinion polls. But the truth is that most children who die in the developing world aren't dying from AIDS. They are dying from the same preventable killers as have stalked them in the past such as diarrhea, pneumonia, and malaria.

LA Times on the vaccine market

This morning's Los Angeles Times ran an editorial on the state of the vaccine industry in light of Pfizer's acquisition of PowderMed:

Two years ago, the closure of one British vaccine plant wreaked havoc on the world's ability to respond to the flu. The investments by Pfizer and others show how market forces, in concert with the nonprofit and public sectors, can work in the public interest

Pages